Filtros : "GlaxoSmithKline" Limpar

Filtros



Refine with date range


  • Source: Chest. Unidade: FM

    Subjects: HIPERTENSÃO PULMONAR, FARMACOTERAPIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SOUZA, Rogerio. Building the Future of Trial Design in PAH on Solid Ground. Chest. Amsterdam: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.chest.2018.01.041. Acesso em: 27 abr. 2026. , 2018
    • APA

      Souza, R. (2018). Building the Future of Trial Design in PAH on Solid Ground. Chest. Amsterdam: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/j.chest.2018.01.041
    • NLM

      Souza R. Building the Future of Trial Design in PAH on Solid Ground [Internet]. Chest. 2018 ; 153( 5): 1089-1090.[citado 2026 abr. 27 ] Available from: https://doi.org/10.1016/j.chest.2018.01.041
    • Vancouver

      Souza R. Building the Future of Trial Design in PAH on Solid Ground [Internet]. Chest. 2018 ; 153( 5): 1089-1090.[citado 2026 abr. 27 ] Available from: https://doi.org/10.1016/j.chest.2018.01.041
  • Source: European respiratory journal. Unidade: FM

    Subjects: APNEIA DO SONO TIPO OBSTRUTIVA, DOENÇAS METABÓLICAS, INCIDÊNCIA, ESTUDOS DE COORTES

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      HIROTSU, Camila e DRAGER, Luciano Ferreira. Obstructive sleep apnoea as a risk factor for incident metabolic syndrome: a joined Episono and HypnoLaus prospective cohorts study. European respiratory journal, v. 52, n. 5, 2018Tradução . . Disponível em: https://doi.org/10.1183/13993003.01150-2018. Acesso em: 27 abr. 2026.
    • APA

      Hirotsu, C., & Drager, L. F. (2018). Obstructive sleep apnoea as a risk factor for incident metabolic syndrome: a joined Episono and HypnoLaus prospective cohorts study. European respiratory journal, 52( 5). doi:10.1183/13993003.01150-2018
    • NLM

      Hirotsu C, Drager LF. Obstructive sleep apnoea as a risk factor for incident metabolic syndrome: a joined Episono and HypnoLaus prospective cohorts study [Internet]. European respiratory journal. 2018 ; 52( 5):[citado 2026 abr. 27 ] Available from: https://doi.org/10.1183/13993003.01150-2018
    • Vancouver

      Hirotsu C, Drager LF. Obstructive sleep apnoea as a risk factor for incident metabolic syndrome: a joined Episono and HypnoLaus prospective cohorts study [Internet]. European respiratory journal. 2018 ; 52( 5):[citado 2026 abr. 27 ] Available from: https://doi.org/10.1183/13993003.01150-2018
  • Source: Psychiatry research. Unidade: FM

    Subjects: FUMO, FUMANTES, FENÓTIPOS, DEPENDENTES QUÍMICOS, SÃO PAULO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CASTALDELLI-MAIA, Joao Mauricio et al. The latent trait of ICD-11 nicotine dependence criteria: dimensional and categorical phenotypes. Psychiatry research, v. 266, p. 275-283, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.psychres.2018.03.018. Acesso em: 27 abr. 2026.
    • APA

      Castaldelli-maia, J. M., Andrade, L. H., Storr, C. L., Viana, M. C., Andrade, A. G. de, & Martins, S. S. (2018). The latent trait of ICD-11 nicotine dependence criteria: dimensional and categorical phenotypes. Psychiatry research, 266, 275-283. doi:10.1016/j.psychres.2018.03.018
    • NLM

      Castaldelli-maia JM, Andrade LH, Storr CL, Viana MC, Andrade AG de, Martins SS. The latent trait of ICD-11 nicotine dependence criteria: dimensional and categorical phenotypes [Internet]. Psychiatry research. 2018 ; 266 275-283.[citado 2026 abr. 27 ] Available from: https://doi.org/10.1016/j.psychres.2018.03.018
    • Vancouver

      Castaldelli-maia JM, Andrade LH, Storr CL, Viana MC, Andrade AG de, Martins SS. The latent trait of ICD-11 nicotine dependence criteria: dimensional and categorical phenotypes [Internet]. Psychiatry research. 2018 ; 266 275-283.[citado 2026 abr. 27 ] Available from: https://doi.org/10.1016/j.psychres.2018.03.018
  • Source: Jcr-journal of clinical rheumatology. Unidade: FM

    Subjects: GUIAS, REUMATOLOGIA, REVISÃO SISTEMÁTICA, TERAPÊUTICA MÉDICA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CARDIEL, Mario H. e BONFA, Eloisa Silva Dutra de Oliveira e SILVA, Clovis Artur Almeida da. Therapeutic guidelines for Latin American Lupus patients methodology. Jcr-journal of clinical rheumatology, v. 24, n. 1, p. 41-44, 2018Tradução . . Disponível em: https://doi.org/10.1097/RHU.0000000000000662. Acesso em: 27 abr. 2026.
    • APA

      Cardiel, M. H., Bonfa, E. S. D. de O., & Silva, C. A. A. da. (2018). Therapeutic guidelines for Latin American Lupus patients methodology. Jcr-journal of clinical rheumatology, 24( 1), 41-44. doi:10.1097/RHU.0000000000000662
    • NLM

      Cardiel MH, Bonfa ESD de O, Silva CAA da. Therapeutic guidelines for Latin American Lupus patients methodology [Internet]. Jcr-journal of clinical rheumatology. 2018 ; 24( 1): 41-44.[citado 2026 abr. 27 ] Available from: https://doi.org/10.1097/RHU.0000000000000662
    • Vancouver

      Cardiel MH, Bonfa ESD de O, Silva CAA da. Therapeutic guidelines for Latin American Lupus patients methodology [Internet]. Jcr-journal of clinical rheumatology. 2018 ; 24( 1): 41-44.[citado 2026 abr. 27 ] Available from: https://doi.org/10.1097/RHU.0000000000000662
  • Source: Journal of the american college of cardiology. Unidade: FM

    Subjects: ANTICOAGULANTES, FIBRILAÇÃO ATRIAL, ACIDENTE VASCULAR CEREBRAL, AMÉRICA LATINA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CORBALAN, Ramon e NICOLAU, Jose Carlos. Edoxaban versus warfarin in Latin American Patients with atrial fibrillation the ENGAGE AF-TIMI 48 trial. Journal of the american college of cardiology, v. 72, n. 13, p. 1466-1475, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.jacc.2018.07.037. Acesso em: 27 abr. 2026.
    • APA

      Corbalan, R., & Nicolau, J. C. (2018). Edoxaban versus warfarin in Latin American Patients with atrial fibrillation the ENGAGE AF-TIMI 48 trial. Journal of the american college of cardiology, 72( 13), 1466-1475. doi:10.1016/j.jacc.2018.07.037
    • NLM

      Corbalan R, Nicolau JC. Edoxaban versus warfarin in Latin American Patients with atrial fibrillation the ENGAGE AF-TIMI 48 trial [Internet]. Journal of the american college of cardiology. 2018 ; 72( 13): 1466-1475.[citado 2026 abr. 27 ] Available from: https://doi.org/10.1016/j.jacc.2018.07.037
    • Vancouver

      Corbalan R, Nicolau JC. Edoxaban versus warfarin in Latin American Patients with atrial fibrillation the ENGAGE AF-TIMI 48 trial [Internet]. Journal of the american college of cardiology. 2018 ; 72( 13): 1466-1475.[citado 2026 abr. 27 ] Available from: https://doi.org/10.1016/j.jacc.2018.07.037
  • Source: Jama-journal of the american medical association. Unidade: FM

    Subjects: DOENÇAS CARDIOVASCULARES, ARTERIOSCLEROSE, MORTALIDADE, ARTÉRIA CARÓTIDA INTERNA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MCINTYRE, William F. e HAJJAR, Ludhmila. Association of Vasopressin Plus Catecholamine Vasopressors vs Catecholamines Alone With Atrial Fibrillation in Patients With Distributive Shock A Systematic Review and Meta-analysis. Jama-journal of the american medical association, v. 319, n. 18, p. 1889-1900, 2018Tradução . . Disponível em: https://doi.org/10.1001/jama.2018.4528. Acesso em: 27 abr. 2026.
    • APA

      Mcintyre, W. F., & Hajjar, L. (2018). Association of Vasopressin Plus Catecholamine Vasopressors vs Catecholamines Alone With Atrial Fibrillation in Patients With Distributive Shock A Systematic Review and Meta-analysis. Jama-journal of the american medical association, 319( 18), 1889-1900. doi:10.1001/jama.2018.4528
    • NLM

      Mcintyre WF, Hajjar L. Association of Vasopressin Plus Catecholamine Vasopressors vs Catecholamines Alone With Atrial Fibrillation in Patients With Distributive Shock A Systematic Review and Meta-analysis [Internet]. Jama-journal of the american medical association. 2018 ; 319( 18): 1889-1900.[citado 2026 abr. 27 ] Available from: https://doi.org/10.1001/jama.2018.4528
    • Vancouver

      Mcintyre WF, Hajjar L. Association of Vasopressin Plus Catecholamine Vasopressors vs Catecholamines Alone With Atrial Fibrillation in Patients With Distributive Shock A Systematic Review and Meta-analysis [Internet]. Jama-journal of the american medical association. 2018 ; 319( 18): 1889-1900.[citado 2026 abr. 27 ] Available from: https://doi.org/10.1001/jama.2018.4528
  • Source: American journal of kidney diseases. Unidade: FM

    Subjects: FALÊNCIA RENAL CRÔNICA, DOENÇAS CARDIOVASCULARES, DIABETES MELLITUS, INFARTO DO MIOCÁRDIO

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CHARYTAN, David M. e BURDMANN, Emmanuel de Almeida. ESRD After Heart Failure, Myocardial Infarction, or Stroke in Type 2 Diabetic Patients With CKD. American journal of kidney diseases, v. 70, n. 4, p. 522-531, 2017Tradução . . Disponível em: http://observatorio.fm.usp.br/handle/OPI/21785. Acesso em: 27 abr. 2026.
    • APA

      Charytan, D. M., & Burdmann, E. de A. (2017). ESRD After Heart Failure, Myocardial Infarction, or Stroke in Type 2 Diabetic Patients With CKD. American journal of kidney diseases, 70( 4), 522-531. doi:10.1053/j.ajkd.2017.04.018
    • NLM

      Charytan DM, Burdmann E de A. ESRD After Heart Failure, Myocardial Infarction, or Stroke in Type 2 Diabetic Patients With CKD [Internet]. American journal of kidney diseases. 2017 ; 70( 4): 522-531.[citado 2026 abr. 27 ] Available from: http://observatorio.fm.usp.br/handle/OPI/21785
    • Vancouver

      Charytan DM, Burdmann E de A. ESRD After Heart Failure, Myocardial Infarction, or Stroke in Type 2 Diabetic Patients With CKD [Internet]. American journal of kidney diseases. 2017 ; 70( 4): 522-531.[citado 2026 abr. 27 ] Available from: http://observatorio.fm.usp.br/handle/OPI/21785
  • Source: BMJ Open. Unidade: FSP

    Subjects: SAÚDE MENTAL, TRANSTORNOS MENTAIS, ESPAÇO URBANO, FATORES SOCIOECONÔMICOS, ESTRUTURA DA FAMÍLIA, DISTRIBUIÇÃO DE RENDA, CHINA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CHIAVEGATTO FILHO, Alexandre Dias Porto et al. Neighbourhood characteristics and mental disorders in three Chinese cities: multilevel models from the World Mental Health Surveys. BMJ Open, v. 7, n. 10, p. art. e01767 [12], 2017Tradução . . Disponível em: https://doi.org/10.1136/bmjopen-2017-017679. Acesso em: 27 abr. 2026.
    • APA

      Chiavegatto Filho, A. D. P., Sampson, L., Martins, S. S., Yu, S., Huang, Y., He, Y., et al. (2017). Neighbourhood characteristics and mental disorders in three Chinese cities: multilevel models from the World Mental Health Surveys. BMJ Open, 7( 10), art. e01767 [12]. doi:10.1136/bmjopen-2017-017679
    • NLM

      Chiavegatto Filho ADP, Sampson L, Martins SS, Yu S, Huang Y, He Y, Lee S, Hu C, Zaslavsky A, Kessler RC, Galea S. Neighbourhood characteristics and mental disorders in three Chinese cities: multilevel models from the World Mental Health Surveys [Internet]. BMJ Open. 2017 ;7( 10): art. e01767 [12].[citado 2026 abr. 27 ] Available from: https://doi.org/10.1136/bmjopen-2017-017679
    • Vancouver

      Chiavegatto Filho ADP, Sampson L, Martins SS, Yu S, Huang Y, He Y, Lee S, Hu C, Zaslavsky A, Kessler RC, Galea S. Neighbourhood characteristics and mental disorders in three Chinese cities: multilevel models from the World Mental Health Surveys [Internet]. BMJ Open. 2017 ;7( 10): art. e01767 [12].[citado 2026 abr. 27 ] Available from: https://doi.org/10.1136/bmjopen-2017-017679
  • Source: Lancet respiratory medicine. Unidade: FM

    Subjects: QUALIDADE DE VIDA, CUIDADOS PALIATIVOS, DOENÇAS PULMONARES INTERSTICIAIS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      KREUTER, Michael e KAIRALLA, Ronaldo Adib. Palliative care in interstitial lung disease: living well. Lancet respiratory medicine, v. 5, n. 12, p. 968-980, 2017Tradução . . Disponível em: https://doi.org/10.1016/S2213-2600(17)30383-1. Acesso em: 27 abr. 2026.
    • APA

      Kreuter, M., & Kairalla, R. A. (2017). Palliative care in interstitial lung disease: living well. Lancet respiratory medicine, 5( 12), 968-980. doi:10.1016/S2213-2600(17)30383-1
    • NLM

      Kreuter M, Kairalla RA. Palliative care in interstitial lung disease: living well [Internet]. Lancet respiratory medicine. 2017 ; 5( 12): 968-980.[citado 2026 abr. 27 ] Available from: https://doi.org/10.1016/S2213-2600(17)30383-1
    • Vancouver

      Kreuter M, Kairalla RA. Palliative care in interstitial lung disease: living well [Internet]. Lancet respiratory medicine. 2017 ; 5( 12): 968-980.[citado 2026 abr. 27 ] Available from: https://doi.org/10.1016/S2213-2600(17)30383-1

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2026